Article
Lentiviral Gene Therapy for Cerebral Adrenoleukodystrophy
9 Oct 2024
Abstract excerpt
BACKGROUND: complementary DNA, is being tested in persons with cerebral adrenoleukodystrophy. METHODS: In a phase 2-3 study, we evaluated the efficacy and safety of eli-cel therapy in boys with early-stage cerebral adrenoleukodystrophy and evidence of active inflammation on magnetic resonance imaging (MRI). The primary efficacy end point was survival without any of six major functional disabilities at month 24....
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
